Johnson & Johnson Income Tax Expense
Johnson & Johnson (JNJ) reported Income Tax Expense of $1.21 billion for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-23
- Johnson & Johnson income tax expense (benefit) for the quarter ending 2026-06-28 was $1.21B, a 27.15% increase year-over-year.
- Johnson & Johnson income tax expense (benefit) for the quarter ending 2026-03-29 was $755.00M, a 71.31% decline year-over-year.
- Johnson & Johnson income tax expense (benefit) for the quarter ending 2025-12-28 was -$150.00M, a 132.89% decline year-over-year.
- Johnson & Johnson income tax expense (benefit) for the quarter ending 2025-09-28 was $2.34B, a 263.51% increase year-over-year.
- Johnson & Johnson income tax expense (benefit) for fiscal 2025 was $5.78B, a 120.41% increase from fiscal 2024.
- Johnson & Johnson income tax expense (benefit) for fiscal 2024 was $2.62B, a 50.98% increase from fiscal 2023.
- Johnson & Johnson income tax expense (benefit) for fiscal 2023 was $1.74B, a 41.92% decline from fiscal 2023.
- Johnson & Johnson income tax expense (benefit) for fiscal 2023 was $2.99B, a 117.07% increase from fiscal 2022.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $1.21B 10-Q · filed 2026-07-23 | $1.97B 10-Q · filed 2026-07-23 | $1.82B derived: sum of 3 quarters · filed 2026-07-23 | $4.16B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2026-03-29 | $755.00M 10-Q · filed 2026-04-22 | $605.00M derived: sum of 2 quarters · filed 2026-04-22 | $2.95B derived: sum of 3 quarters · filed 2026-04-22 | $3.90B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-12-28 | -$150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $2.19B derived: sum of 2 quarters · filed 2026-02-11 | $3.15B derived: sum of 3 quarters · filed 2026-07-23 | $5.78B 10-K · filed 2026-02-11 | ||||
| 2025-09-28 | $2.34B 10-Q · filed 2025-10-22 | $3.29B derived: sum of 2 quarters · filed 2026-07-23 | $5.93B 10-Q · filed 2025-10-22 | $6.38B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-06-29 | $954.00M 10-Q · filed 2026-07-23 | $3.59B 10-Q · filed 2026-07-23 | $4.04B derived: sum of 3 quarters · filed 2026-07-23 | $4.69B derived: sum of 4 quarters · filed 2026-07-23 | ||||
| 2025-03-30 | $2.63B 10-Q · filed 2026-04-22 | $3.09B derived: sum of 2 quarters · filed 2026-04-22 | $3.73B derived: sum of 3 quarters · filed 2026-04-22 | $4.79B derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-12-29 | $456.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.10B derived: sum of 2 quarters · filed 2026-02-11 | $2.16B derived: sum of 3 quarters · filed 2026-02-11 | $2.62B 10-K · filed 2026-02-11 | ||||
| 2024-09-29 | $644.00M 10-Q · filed 2025-10-22 | $1.71B derived: sum of 2 quarters · filed 2025-10-22 | $2.17B 10-Q · filed 2025-10-22 | $2.86B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-06-30 | $1.06B 10-Q · filed 2025-07-24 | $1.52B 10-Q · filed 2025-07-24 | $2.21B derived: sum of 3 quarters · filed 2026-02-11 | $3.12B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-03-31 | $459.00M 10-Q · filed 2025-04-23 | $1.15B derived: sum of 2 quarters · filed 2026-02-11 | $2.06B derived: sum of 3 quarters · filed 2026-02-11 | $2.99B derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2023-12-31 | $694.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.60B derived: sum of 2 quarters · filed 2026-02-11 | $2.53B derived: sum of 3 quarters · filed 2026-02-11 | $1.74B 10-K · filed 2026-02-11 | ||||
| 2023-10-01 | $908.00M 10-Q · filed 2024-10-23 | $1.84B derived: sum of 2 quarters · filed 2024-10-23 | $1.04B 10-Q · filed 2024-10-23 | $1.66B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-07-02 | $930.00M 10-Q · filed 2024-07-25 | $1.62B 10-Q · filed 2023-07-31 | $134.00M 10-Q · filed 2024-07-25 | $949.00M 10-Q · filed 2023-07-31 | $747.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.61B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-04-02 | -$796.00M 10-Q · filed 2024-05-01 | -$669.00M 10-Q · filed 2023-04-28 | -$183.00M derived: sum of 2 quarters · filed 2025-02-13 | $679.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.71B derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-01-01 | $613.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.48B derived: sum of 2 quarters · filed 2025-02-13 | $2.50B derived: sum of 3 quarters · filed 2025-02-13 | $2.99B 10-K · filed 2025-02-13 | $3.78B 10-K · filed 2023-02-16 | |||
| 2022-10-02 | $862.00M 10-Q · filed 2023-10-27 | $1.36B 10-Q · filed 2022-10-27 | $1.89B derived: sum of 2 quarters · filed 2023-10-27 | $2.38B 10-Q · filed 2023-10-27 | $3.10B 10-Q · filed 2022-10-27 | $2.18B derived: sum of 4 quarters · filed 2024-02-16 | ||
| 2022-07-03 | $1.03B 10-Q · filed 2023-07-31 | $1.74B 10-Q · filed 2023-07-31 | $1.32B derived: sum of 3 quarters · filed 2024-02-16 | $1.50B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-04-03 | $713.00M 10-Q · filed 2023-04-28 | $292.00M derived: sum of 2 quarters · filed 2024-02-16 | $474.00M derived: sum of 3 quarters · filed 2024-02-16 | $858.00M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-01-02 | -$421.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$239.00M derived: sum of 2 quarters · filed 2024-02-16 | $145.00M derived: sum of 3 quarters · filed 2024-02-16 | $1.38B 10-K · filed 2024-02-16 | $1.90B 10-K · filed 2022-02-17 | |||
| 2021-10-03 | $182.00M 10-Q · filed 2022-10-27 | $566.00M derived: sum of 2 quarters · filed 2022-10-27 | $1.80B 10-Q · filed 2022-10-27 | $1.71B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-07-04 | $384.00M 10-Q · filed 2022-07-29 | $1.62B 10-Q · filed 2022-07-29 | $1.52B derived: sum of 3 quarters · filed 2023-02-16 | $2.37B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-04-04 | $1.23B 10-Q · filed 2022-04-29 | $1.14B derived: sum of 2 quarters · filed 2023-02-16 | $1.99B derived: sum of 3 quarters · filed 2023-02-16 | $2.30B derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-01-03 | -$91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $756.00M derived: sum of 2 quarters · filed 2023-02-16 | $1.07B derived: sum of 3 quarters · filed 2023-02-16 | $1.78B 10-K · filed 2023-02-16 | ||||
| 2020-09-27 | $847.00M 10-Q · filed 2021-10-29 | $1.16B derived: sum of 2 quarters · filed 2021-10-29 | $1.87B 10-Q · filed 2021-10-29 | $2.08B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-28 | $314.00M 10-Q · filed 2021-07-29 | $1.03B 10-Q · filed 2021-07-29 | $1.24B derived: sum of 3 quarters · filed 2022-02-17 | $1.13B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-29 | $713.00M 10-Q · filed 2021-04-30 | $921.00M derived: sum of 2 quarters · filed 2022-02-17 | $815.00M derived: sum of 3 quarters · filed 2022-02-17 | $2.25B derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-29 | $208.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $102.00M derived: sum of 2 quarters · filed 2022-02-17 | $1.54B derived: sum of 3 quarters · filed 2022-02-17 | $2.21B 10-K · filed 2022-02-17 | ||||
| 2019-09-29 | -$106.00M 10-Q · filed 2020-10-23 | $1.33B derived: sum of 2 quarters · filed 2020-10-23 | $2.00B 10-Q · filed 2020-10-23 | $2.08B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $1.43B 10-Q · filed 2020-07-24 | $2.11B 10-Q · filed 2020-07-24 | $2.19B derived: sum of 3 quarters · filed 2021-02-22 | $2.68B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $673.00M 10-Q · filed 2020-04-29 | $753.00M derived: sum of 2 quarters · filed 2021-02-22 | $1.24B derived: sum of 3 quarters · filed 2021-02-22 | $2.26B derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-30 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $569.00M derived: sum of 2 quarters · filed 2021-02-22 | $1.59B derived: sum of 3 quarters · filed 2021-02-22 | $2.70B 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $489.00M 10-Q · filed 2019-10-28 | $1.51B derived: sum of 2 quarters · filed 2019-10-28 | $2.62B 10-Q · filed 2019-10-28 | $15.89B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-07-01 | $1.02B 10-Q · filed 2019-07-29 | $2.13B 10-Q · filed 2019-07-29 | $15.41B derived: sum of 3 quarters · filed 2020-02-18 | $16.43B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2018-04-01 | $1.11B 10-Q · filed 2019-05-01 | $14.39B derived: sum of 2 quarters · filed 2020-02-18 | $15.41B derived: sum of 3 quarters · filed 2020-02-18 | $16.33B derived: sum of 4 quarters · filed 2020-02-18 | ||||
| 2017-12-31 | $13.27B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $14.30B derived: sum of 2 quarters · filed 2020-02-18 | $15.22B derived: sum of 3 quarters · filed 2020-02-18 | $16.37B 10-K · filed 2020-02-18 | ||||
| 2017-10-01 | $1.03B 10-Q · filed 2018-10-31 | $1.95B derived: sum of 2 quarters · filed 2018-10-31 | $3.10B 10-Q · filed 2018-10-31 | $3.61B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-07-02 | $921.00M 10-Q · filed 2018-08-02 | $2.07B 10-Q · filed 2018-08-02 | $2.58B derived: sum of 3 quarters · filed 2019-02-20 | $3.59B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-04-02 | $1.15B 10-Q · filed 2018-05-01 | $1.66B derived: sum of 2 quarters · filed 2019-02-20 | $2.67B derived: sum of 3 quarters · filed 2019-02-20 | $3.58B derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-01-01 | $510.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.52B derived: sum of 2 quarters · filed 2019-02-20 | $2.43B derived: sum of 3 quarters · filed 2019-02-20 | $3.26B 10-K · filed 2019-02-20 | ||||
| 2016-10-02 | $1.01B 10-Q · filed 2017-11-02 | $1.92B derived: sum of 2 quarters · filed 2017-11-02 | $2.75B 10-Q · filed 2017-11-02 | $3.30B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-07-03 | $907.00M 10-Q · filed 2017-08-03 | $1.74B 10-Q · filed 2017-08-03 | $2.29B derived: sum of 3 quarters · filed 2018-02-21 | $3.05B derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-04-03 | $837.00M 10-Q · filed 2017-05-08 | $1.00B 10-Q · filed 2016-05-10 | $1.38B derived: sum of 2 quarters · filed 2018-02-21 | $2.14B derived: sum of 3 quarters · filed 2018-02-21 | $3.37B derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-01-03 | $543.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $1.31B derived: sum of 2 quarters · filed 2018-02-21 | $2.53B derived: sum of 3 quarters · filed 2018-02-21 | $3.79B 10-K · filed 2018-02-21 | ||||
| 2015-09-27 | $764.00M 10-Q · filed 2016-11-04 | $1.99B derived: sum of 2 quarters · filed 2016-11-04 | $3.24B 10-Q · filed 2016-11-04 | $3.43B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-28 | $1.23B 10-Q · filed 2016-08-04 | $2.48B 10-Q · filed 2016-08-04 | $2.66B derived: sum of 3 quarters · filed 2017-02-27 | $4.72B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-29 | $1.25B 10-Q · filed 2016-05-10 | $1.44B derived: sum of 2 quarters · filed 2017-02-27 | $3.50B derived: sum of 3 quarters · filed 2017-02-27 | $4.80B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-28 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.24B derived: sum of 2 quarters · filed 2017-02-27 | $3.54B derived: sum of 3 quarters · filed 2017-02-27 | $4.24B 10-K · filed 2017-02-27 | ||||
| 2014-09-28 | $2.06B 10-Q · filed 2015-10-30 | $3.36B derived: sum of 2 quarters · filed 2015-10-30 | $4.06B 10-Q · filed 2015-10-30 | $3.29B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-06-29 | $1.30B 10-Q · filed 2015-07-31 | $2.00B 10-Q · filed 2015-07-31 | $1.23B derived: sum of 3 quarters · filed 2016-02-24 | $1.91B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2014-03-30 | $697.00M 10-Q · filed 2015-05-01 | -$72.00M derived: sum of 2 quarters · filed 2016-02-24 | $613.00M derived: sum of 3 quarters · filed 2016-02-24 | $1.57B derived: sum of 4 quarters · filed 2016-02-24 | ||||
| 2013-12-29 | -$769.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$84.00M derived: sum of 2 quarters · filed 2016-02-24 | $876.00M derived: sum of 3 quarters · filed 2016-02-24 | $1.64B 10-K · filed 2016-02-24 | ||||
| 2013-09-29 | $685.00M 10-Q · filed 2014-10-30 | $1.65B derived: sum of 2 quarters · filed 2014-10-30 | $2.41B 10-Q · filed 2014-10-30 | $2.94B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $960.00M 10-Q · filed 2014-08-01 | $1.72B 10-Q · filed 2014-08-01 | $2.26B derived: sum of 3 quarters · filed 2015-02-24 | $3.22B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $764.00M 10-Q · filed 2014-05-02 | $1.30B derived: sum of 2 quarters · filed 2015-02-24 | $2.26B derived: sum of 3 quarters · filed 2015-02-24 | $2.89B derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-30 | $533.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.50B derived: sum of 2 quarters · filed 2015-02-24 | $2.13B derived: sum of 3 quarters · filed 2015-02-24 | $3.26B 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $966.00M 10-Q · filed 2013-11-04 | $1.59B derived: sum of 2 quarters · filed 2013-11-04 | $2.73B 10-Q · filed 2013-11-04 | $2.83B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-07-01 | $627.00M 10-Q · filed 2013-08-01 | $1.76B 10-Q · filed 2013-08-01 | $1.86B derived: sum of 3 quarters · filed 2014-02-21 | $2.77B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-04-01 | $1.14B 10-Q · filed 2013-05-03 | $1.24B derived: sum of 2 quarters · filed 2014-02-21 | $2.14B derived: sum of 3 quarters · filed 2014-02-21 | $2.79B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-01-01 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $1.01B derived: sum of 2 quarters · filed 2014-02-21 | $1.66B derived: sum of 3 quarters · filed 2014-02-21 | $2.69B 10-K · filed 2014-02-21 | ||||
| 2011-10-02 | $909.00M 10-Q · filed 2012-11-09 | $1.55B derived: sum of 2 quarters · filed 2012-11-09 | $2.59B 10-Q · filed 2012-11-09 | $2.88B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-07-03 | $646.00M 10-Q · filed 2012-08-02 | $1.68B 10-Q · filed 2012-08-02 | $1.97B derived: sum of 3 quarters · filed 2013-02-22 | $2.77B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-04-03 | $1.03B 10-Q · filed 2012-05-07 | $1.32B derived: sum of 2 quarters · filed 2013-02-22 | $2.12B derived: sum of 3 quarters · filed 2013-02-22 | $2.89B derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-01-02 | $286.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $1.09B derived: sum of 2 quarters · filed 2013-02-22 | $1.86B derived: sum of 3 quarters · filed 2013-02-22 | $3.61B 10-K · filed 2013-02-22 | ||||
| 2010-10-03 | $802.00M 10-Q · filed 2011-11-08 | $1.57B derived: sum of 2 quarters · filed 2011-11-08 | $3.33B 10-Q · filed 2011-11-08 | $3.73B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-07-04 | $771.00M 10-Q · filed 2011-08-09 | $2.52B 10-Q · filed 2011-08-09 | $2.92B derived: sum of 3 quarters · filed 2012-02-23 | $3.82B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-04-04 | $1.75B 10-Q · filed 2011-05-10 | $2.15B derived: sum of 2 quarters · filed 2012-02-23 | $3.05B derived: sum of 3 quarters · filed 2012-02-23 | $4.11B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-01-03 | $398.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $1.30B derived: sum of 2 quarters · filed 2012-02-23 | $2.35B derived: sum of 3 quarters · filed 2012-02-23 | $3.49B 10-K · filed 2012-02-23 | ||||
| 2009-09-27 | $900.00M 10-Q · filed 2010-11-10 | $1.96B derived: sum of 2 quarters · filed 2010-11-10 | $3.09B 10-Q · filed 2010-11-10 | $3.89B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-06-28 | $1.05B 10-Q · filed 2010-08-11 | $2.19B 10-Q · filed 2010-08-11 | $2.99B derived: sum of 3 quarters · filed 2011-02-25 | $3.97B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2009-03-29 | $1.14B 10-Q · filed 2010-05-10 | $1.94B derived: sum of 2 quarters · filed 2011-02-25 | $2.92B derived: sum of 3 quarters · filed 2011-02-25 | $3.97B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-28 | $803.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $1.78B derived: sum of 2 quarters · filed 2011-02-25 | $2.83B derived: sum of 3 quarters · filed 2011-02-25 | $3.98B 10-K · filed 2011-02-25 | ||||
| 2008-09-28 | $980.00M 10-Q · filed 2009-11-04 | $2.03B derived: sum of 2 quarters · filed 2009-11-04 | $3.18B 10-Q · filed 2009-11-04 | |||||
| 2008-06-29 | $1.05B 10-Q · filed 2009-08-04 | $2.20B 10-Q · filed 2009-08-04 | ||||||
| 2007-12-30 | $2.71B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |